ADVERTISEMENT
fda largenotapprovedstamp

FDA defends CRISPR-edited animal rules likely to block most uses: Is the agency trying to avoid litigation from anti-GMO groups?

"How can the presence of one identifiable variant justify the costs and delays of mandatory FDA oversight?" ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists